Market Overview:
The global sturge weber syndrome (SWS) treatment market is expected to register a CAGR of 7.8% during the forecast period, 2018-2030. The market growth can be attributed to factors such as increasing prevalence of SWS, rising awareness about the disease and its treatment options, and technological advancements in the field of laser therapy and surgical procedures. However, high cost associated with diagnosis and treatment is likely to restrain the growth of this market during the forecast period. Based on type, the global SWS treatment market can be segmented into medication, laser therapy, and surgical procedures. The medication segment is further sub-segmented into anticonvulsants drugs and corticosteroids drugs. The laser therapy segment is further sub-segmented into pulsed dye lasers (PDLs), carbon dioxide lasers (CO2), neodymium:yttrium aluminum garnet (Nd:YAG) lasers, argon lasers (ArLs), potassium titanyl phosphate (KTP) lasers Others). Surgical procedures are further classified as excisional surgery or lesionectomy surgery; enucleation surgery; superficial temporal artery ligation surgery; stereotactic radiosurgery/gamma knife radiosurgery; embolization procedure for AVMs etc.).
 Treatment Industry Outlook.svg)
Product Definition:
A congenital disorder characterized by a triad of symptoms including a port-wine stain on the face, seizures, and mental retardation. The cause is unknown, but it may be related to abnormal blood vessel development. Treatment includes medications to control seizures and surgery to correct any physical abnormalities.
Medication:
Medication is the use of drugs to treat a disease or disorder. The most common types of medications used in the treatment of SWS are anti-epileptic drugs and sedatives. Anticonvulsants, stimulants, and antidepressants are also used in some cases.
Anticonvulsants: These medications suppress or control seizures by altering levels of certain chemicals in the brain.
Laser Therapy:
Laser therapy is a minimally invasive procedure used for the treatment of various eye disorders. It uses light to cure and heal the affected areas of the body without causing any harm to surrounding tissues or organs. Laser therapy is mainly used for two conditions namely, diabetic macular edema (DME) and retinitis pigmentosa (RP).
Application Insights:
Based on application, the global sturge weber syndrome (SWS) treatment market is segmented into hospitals, clinics, diagnostic centers and others. Hospitals held the largest share in 2017 owing to availability of advanced healthcare facilities and highly skilled medical staffs. In addition SWS treatment in hospitals offers a number of benefits including precise diagnosis with higher accuracy due to advanced equipment such as imaging devices and laboratory tests. Furthermore, hospital-based care allows for more frequent visits which may be required due to complications associated with sturge weber syndrome thus resulting in higher revenue generation compared to that through other channels over the forecast period.
The clinics segment is expected register fastest CAGR during forecast years owing to rising awareness about available treatments coupled with increasing government initiatives towards this end along with an increase in patients seeking medical advice regarding symptoms persisting despite a proper diagnosis at an early stage by specialists at these centers thus driving growth over the projected period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the availability of advanced technologies, high adoption rate of innovative techniques and a large number of patients suffering from this condition. The presence of key players is also expected to boost regional growth over the forecast period.
Asia Pacific is expected to grow at a lucrative CAGR during the forecast period owing to increasing healthcare expenditure by governments and private sectors as well as rising awareness about treatment options for Sturge-Weber syndrome in this region. Moreover, increasing medical tourism due to affordable treatments offered by countries such as Japan and China are contributing towards regional growth.
The key players operating in Asia Pacific are Stryker Corporation; Boston Scientific Corporation; Medtronic Diabetes Care Pvt Ltd.; Novo Nordisk A/S; Johnson & Johnson Services India Pvt Ltd.
Growth Factors:
- Increasing awareness about Sturge Weber Syndrome (SWS) Treatment and its symptoms among people, which is likely to drive the demand for Sturge Weber Syndrome (SWS) Treatment market in the near future.
- Rising number of research and development activities for new treatment methods of Sturge Weber Syndrome (SWS) Treatment is expected to propel the growth of this market in forthcoming years.
- Growing number of initiatives by government and private organizations to increase awareness about Sturge Weber Syndrome (SWS) Treatment is projected to fuel the demand for this market over the forecast period.
- Technological advancements in diagnosis and treatment procedures for Sturge Weber Syndrome (SWS) are anticipated to create lucrative opportunities for players operating in this market during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Sturge Weber Syndrome (SWS) Treatment Market Research Report
By Type
Medication, Laser Therapy, Surgical Procedures
By Application
Hospitals, Clinics, Diagnostic Centers, Others
By Companies
Abbott, Pfizer, Roche, Novartis, Johnson & Johnson, UCB, Sanofi, Takeda, Aleva Neurotherapeutics, GW Pharmaceuticals, ElectroCore
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
212
Number of Tables & Figures
149
Customization Available
Yes, the report can be customized as per your need.
Global Sturge Weber Syndrome (SWS) Treatment Market Report Segments:
The global Sturge Weber Syndrome (SWS) Treatment market is segmented on the basis of:
Types
Medication, Laser Therapy, Surgical Procedures
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Diagnostic Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Pfizer
- Roche
- Novartis
- Johnson & Johnson
- UCB
- Sanofi
- Takeda
- Aleva Neurotherapeutics
- GW Pharmaceuticals
- ElectroCore
 Treatment Market Overview.svg)
Highlights of The Sturge Weber Syndrome (SWS) Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Medication
- Laser Therapy
- Surgical Procedures
- By Application:
- Hospitals
- Clinics
- Diagnostic Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sturge Weber Syndrome (SWS) Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Treatment Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no specific treatment for Sturge Weber Syndrome (SWS), but the condition can be managed with medication and/or surgery. Treatment typically includes medications to control seizures, surgery to remove the tumor or cyst, and radiation therapy.
Some of the major companies in the sturge weber syndrome (sws) treatment market are Abbott, Pfizer, Roche, Novartis, Johnson & Johnson, UCB, Sanofi, Takeda, Aleva Neurotherapeutics, GW Pharmaceuticals, ElectroCore.
The sturge weber syndrome (sws) treatment market is expected to grow at a compound annual growth rate of 7.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Sturge Weber Syndrome (SWS) Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Sturge Weber Syndrome (SWS) Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Sturge Weber Syndrome (SWS) Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Sturge Weber Syndrome (SWS) Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Sturge Weber Syndrome (SWS) Treatment Market Size & Forecast, 2020-2028
4.5.1 Sturge Weber Syndrome (SWS) Treatment Market Size and Y-o-Y Growth
4.5.2 Sturge Weber Syndrome (SWS) Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Medication
5.2.2 Laser Therapy
5.2.3 Surgical Procedures
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Diagnostic Centers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Sturge Weber Syndrome (SWS) Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Sturge Weber Syndrome (SWS) Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Medication
9.6.2 Laser Therapy
9.6.3 Surgical Procedures
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Diagnostic Centers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Medication
10.6.2 Laser Therapy
10.6.3 Surgical Procedures
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Diagnostic Centers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Medication
11.6.2 Laser Therapy
11.6.3 Surgical Procedures
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Diagnostic Centers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Medication
12.6.2 Laser Therapy
12.6.3 Surgical Procedures
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Diagnostic Centers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Medication
13.6.2 Laser Therapy
13.6.3 Surgical Procedures
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Diagnostic Centers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Sturge Weber Syndrome (SWS) Treatment Market: Competitive Dashboard
14.2 Global Sturge Weber Syndrome (SWS) Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Pfizer
14.3.3 Roche
14.3.4 Novartis
14.3.5 Johnson & Johnson
14.3.6 UCB
14.3.7 Sanofi
14.3.8 Takeda
14.3.9 Aleva Neurotherapeutics
14.3.10 GW Pharmaceuticals
14.3.11 ElectroCore
